Lucentis Fsv4 Lad Amd Ladder
Research payments
$4,427,703
Through program year 2021, $4,427,703 in research payments was reported against Lucentis Fsv4 Lad Amd Ladder, across 606 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $6,542 | 1 |
| 2020 | Research | $1,299,427 | 123 |
| 2019 | Research | $3,121,734 | 482 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Carl Awh Nashville, TN Named on 63 payments
- Richard Dreyer Portland, OR Named on 59 payments
- Brian Berger Austin, TX Named on 41 payments
- David Eichenbaum Saint Petersburg, FL Named on 37 payments
- David Brown Houston, TX Named on 23 payments
- Robert Bhisitkul San Francisco, CA Named on 21 payments
- William Freeman La Jolla, CA Named on 21 payments
- Andreas Lauer Portland, OR Named on 20 payments
- John Thompson Towson, MD Named on 14 payments
- Jordan Graff Phoenix, AZ Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.